SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 5.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 54.2. According to RSI analysis, sunpharma is technically strong. 9.0 SUNPHARMA RSI Chart
MACD (?) MACD: 10.2 and Signal Line: 12.1. According to MACD analysis, sunpharma is marginally weak. 3.0 SUNPHARMA MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, sunpharma is facing resistance from it's 20-day simple moving average at 574.23 and support level is at 551. 2.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is in a uptrend. Support level is at 571. 9.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.458. 5.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 563.9552 and 551.4. Resistance level is 604.6. 6.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 14.6 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 27.6 which means SUNPHARMA is in a trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 19, 2018
Open Price 580.0
High Price 580.65
Low Price 567.6
Close Price 572.1
Absolute Change -4.6
Percentage Change -0.798%
Weekly Change -1.95%
Monthly Change 8.31%
Yearly Change -11.9%
52-week high 729.05
52-week low 432.7
Corporate Actions
ExDate Purpose
September 18, 2017 AGM/DIV-RS 3.50 PER SHARE
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.607
Confidence in Beta1.91%
Market Capital Rs. 137687.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 64.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 January 2018: Deliverable Quantity:2.53e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 January 2018: Daily Volatility:0.2885 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 January 2018: PCR_OI:0.551 PCR:0.32 NA SUNPHARMA PCR Chart
Option Pain (?) 19 January 2018: Max Pain:580.0 NA SUNPHARMA Option Pain Chart
Premium (?) 19 January 2018 Premium: 1.75 Futures OI:45094500.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 19 January 2018: Price:572.1 Put with maximum OI:500.0 Call with maximum OI:600.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 573.85 45094500.0 8491.0 12769.0 572.1
February 22, 2018 576.45 9821900.0 2826.0 6377.0 572.1
March 28, 2018 578.9 171600.0 25.0 25.0 572.1

Announcements

January 09, 2018 SUpdatesSun Pharmaceutical Industries Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
December 27, 2017 SPress Release (Revised)Sun Pharmaceutical Industries Limited has informed the Exchange regarding a revised press release dated December 27, 2017, titled "Sun Pharma Announces US FDA Acceptance of NDA for OTX-101".
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 30, 2017 November 14, 2017 tResultsto consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017.
July 26, 2017 August 11, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 553.2 Rs. 560.4 Rs. 566.2 Rs. 573.4 Rs. 579.3 Rs. 586.5 Rs. 592.3